SAVE $10 on $100 Orders* • Use code BNR91420

B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)


We assessed the role of B7-1 and B7-2 costimulatory molecules on the course of murine
Lyme borreliosis because experimental
Lyme arthritis is dependent, at least partially, upon the development of the host immune response and these costimulatory molecules have been implicated in CD4+ T-cell differentiation. We demonstrated that Borrelia burgdorferi infection upregulated the surface expression of B7-1 and B7-2 in macrophages and B7-2 expression in B cells. Anti-B7-2 monoclonal antibody (MAb) or both anti-B7-2 and anti-B7-1 MAbs produced a dose-dependent increase in the severity of
Lyme arthritis in C3H/HeN mice. In contrast, the administration of an anti-B7-1 MAb reduced the degree of arthritis. These effects occurred independently of significant alteration in B. burgdorferi-specific immune responses, including splenocyte proliferative responses to B. burgdorferi, B. burgdorferi antibody levels and specificity, and mRNA levels of gamma interferon, interleukin-4 (IL-4), IL-10, and IL-12 in the spleen. These results demonstrate that signaling delivered by B7-1 and B7-2 plays a role in determining the severity of acute murine
Lyme arthritis.

Infect Immun. 1997 Aug;65(8):3037-41. Research Support, Non-U.S. Gov’t; Research Support, U.S. Gov’t, P.H.S.

ProHealth CBD Store


1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave a Reply